ELA vs. ARWR

Last updated Jun 4, 2026

ELA (Envela Corporation) and ARWR (Arrowhead Pharmaceuticals, Inc.) are both stocks. ELA operates in Luxury Goods (Consumer Cyclical), while ARWR operates in Biotechnology (Healthcare). Over the past 10 years, ELA returned 44.94%/yr vs 28.05%/yr for ARWR. At a 0.06 correlation, their price movements are largely independent.

Performance

ELA vs. ARWR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Envela Corporation (ELA) and Arrowhead Pharmaceuticals, Inc. (ARWR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ELA achieves a 80.34% return, which is significantly higher than ARWR's 9.28% return. Over the past 10 years, ELA has outperformed ARWR with an annualized return of 44.94%, while ARWR has yielded a comparatively lower 28.05% annualized return.

ELA

• 1D: -2.07%
• 1M: 43.97%
• YTD: 80.34%
• 6M: 84.76%
• 1Y: 318.20%
• 3Y*: 47.63%
• 5Y*: 36.35%
• 10Y*: 44.94%

ARWR

• 1D: 2.44%
• 1M: -5.03%
• YTD: 9.28%
• 6M: 11.49%
• 1Y: 336.79%
• 3Y*: 26.25%
• 5Y*: -0.96%
• 10Y*: 28.05%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ELA vs. ARWR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ELA Envela Corporation	80.34%	86.35%	47.74%	-7.60%	29.24%	-21.73%	285.19%	193.54%	-50.55%	-25.00%
ARWR Arrowhead Pharmaceuticals, Inc.	9.28%	253.14%	-38.56%	-24.56%	-38.82%	-13.59%	20.97%	410.71%	237.50%	137.42%

Correlation

The correlation between ELA and ARWR is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.11
Correlation (3Y) Calculated over the trailing 3-year period	0.18
Correlation (5Y) Calculated over the trailing 5-year period	0.19
Correlation (10Y) Calculated over the trailing 10-year period	0.12
Correlation (All Time) Calculated using the full available price history since Jan 7, 1997	0.06

The correlation between ELA and ARWR shifts across timeframes, from 0.06 (all time) to 0.19 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ELA : $626.50M ARWR : $10.33B
EPS ELA : $0.81 ARWR : -$2.16
PS Ratio ELA : 2.15 ARWR : 16.27
PB Ratio ELA : 8.25 ARWR : 17.25
Total Revenue (TTM) ELA : $291.15M ARWR : $622.01M
Gross Profit (TTM) ELA : $62.58M ARWR : $529.27M
EBITDA (TTM) ELA : $22.99M ARWR : -$168.38M

Return for Risk

ELA vs. ARWR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELA

ELA Risk / Return Rank: 97
ELA Sharpe Ratio Rank: 98
ELA Sortino Ratio Rank: 96
ELA Omega Ratio Rank: 95
ELA Calmar Ratio Rank: 99
ELA Martin Ratio Rank: 99

ARWR

ARWR Risk / Return Rank: 98
ARWR Sharpe Ratio Rank: 99
ARWR Sortino Ratio Rank: 97
ARWR Omega Ratio Rank: 95
ARWR Calmar Ratio Rank: 98
ARWR Martin Ratio Rank: 98

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELA vs. ARWR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Envela Corporation (ELA) and Arrowhead Pharmaceuticals, Inc. (ARWR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ELA	ARWR	Difference
Sharpe ratio Return per unit of total volatility	4.50	5.22	-0.72
Sortino ratio Return per unit of downside risk	4.54	4.69	-0.15
Omega ratio Gain probability vs. loss probability	1.58	1.59	-0.01
Calmar ratio Return relative to maximum drawdown	14.73	13.77	+0.96
Martin ratio Return relative to average drawdown	46.47	37.74	+8.73
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ELA vs. ARWR - Sharpe Ratio Comparison

The current ELA Sharpe Ratio is 4.50, which is comparable to the ARWR Sharpe Ratio of 5.22. The chart below compares the historical Sharpe Ratios of ELA and ARWR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ELA	ARWR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	4.50	5.22	-0.72
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.67	-0.01	+0.69
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.68	0.38	+0.30
Sharpe Ratio (All Time) Calculated using the full available price history	0.08	-0.01	+0.08

Drawdowns

ELA vs. ARWR - Drawdown Comparison

The maximum ELA drawdown since its inception was -97.32%, roughly equal to the maximum ARWR drawdown of -99.24%. Use the drawdown chart below to compare losses from any high point for ELA and ARWR.

Drawdown Indicators

	ELA	ARWR	Difference
Max Drawdown Largest peak-to-trough decline	-97.32%	-99.24%	+1.92%
Max Drawdown (1Y) Largest decline over 1 year	-21.77%	-24.64%	+2.87%
Max Drawdown (3Y) Largest decline over 3 years	-59.24%	-74.70%	+15.46%
Max Drawdown (5Y) Largest decline over 5 years	-61.53%	-88.94%	+27.41%
Max Drawdown (10Y) Largest decline over 10 years	-78.03%	-88.96%	+10.93%
Current Drawdown Current decline from peak	-12.29%	-55.35%	+43.06%
Average Drawdown Average peak-to-trough decline	-57.66%	-81.24%	+23.58%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.90%	8.97%	-2.07%

Volatility

ELA vs. ARWR - Volatility Comparison

Envela Corporation (ELA) has a higher volatility of 28.22% compared to Arrowhead Pharmaceuticals, Inc. (ARWR) at 17.17%. This indicates that ELA's price experiences larger fluctuations and is considered to be riskier than ARWR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ELA	ARWR	Difference
Volatility (1M) Calculated over the trailing 1-month period	28.22%	17.17%	+11.05%
Volatility (6M) Calculated over the trailing 6-month period	59.00%	39.41%	+19.59%
Volatility (1Y) Calculated over the trailing 1-year period	71.22%	65.03%	+6.19%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	54.38%	65.03%	-10.65%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	66.24%	74.14%	-7.90%

Dividends

ELA vs. ARWR - Dividend Comparison

Neither ELA nor ARWR has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ELA and ARWR in my portfolio?

ELA and ARWR have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ELA or ARWR?

ELA has higher volatility (28.22%) compared to ARWR (17.17%). In terms of maximum drawdown, ELA dropped -97.32% vs ARWR's -99.24%.

Which has better risk-adjusted returns?

ARWR currently has the higher Sharpe Ratio (5.22 vs 4.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.